Meeting
2013 ASCO Annual Meeting
Completion of adjuvant trastuzumab for older patients with early-stage breast cancer (BC).
Authors
Rachel A. Freedman
Dana-Farber Cancer Institute, Boston, MA
Rachel A. Freedman , Ines Maria Vaz Duarte Luis , Nancy Lin , Joyce Lii , Eric P. Winer , Nancy Lynn Keating
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - HER2/ER
Track
Breast Cancer
Sub Track
HER2+
Citation
J Clin Oncol 31, 2013 (suppl; abstr 616)
DOI
10.1200/jco.2013.31.15_suppl.616
Abstract #
616
Poster Bd #
10G
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Potentially inappropriate medication use in elderly breast cancer patients.
First Author: Meghan Sri Karuturi
Poster
2012 ASCO Quality Care Symposium
Patterns and predictors of chemotherapy and trastuzumab use for early-stage breast cancer in Kaiser Permanente Northern California, 2004-2007.
First Author: Allison Kurian
Poster
2023 ASCO Annual Meeting
The evolving landscape of chemotherapy for the treatment of early-stage breast cancer from 2006-2019: Results of a retrospective cohort study.
First Author: Jenna Bhimani
Poster
2023 ASCO Annual Meeting
Oral paclitaxel, carboplatin, and dostarlimab (OPE/Cb/D) without and with trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL.
First Author: Kay T Yeung